福泰制药 VRTX 深 沪
等待开盘 01-28 09:30:00 美东时间
474.17
-2.670
-0.56%
华盛通- 最 高485.00
- 今 开476.80
- 成交量 163.19万股
- 最 低 470.49
- 昨 收 476.84
- 总市值 1204.39亿
- 52周最高 519.68
- 市盈率 静 --
- 换手率 0.64%
- 52周最低 362.50
- 委 比 -92.03%
- 总股本 2.54亿
- 历史最高 519.88
- 量 比 0.95
- 振 幅 3.04%
- 历史最低 26.50
- 每 手 1
- 风险率 35.11%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 斯伦贝谢、SouthState Bank、西屋制动、特里科银行获多家大行上调目标价；苹果、meta、微软等绩前遭下调目标价
今日重点评级关注：Oppenheimer：维持Pelthos Therapeutics"跑赢大市"评级，目标价从57美元升至60美元；Small Cap Consumer Research：维持Lands' End"买入"评级，目标价从20美元升至45美元
01-27 10:02
UBS Maintains Buy on Vertex Pharmaceuticals, Raises Price Target to $545
UBS analyst Michael Yee maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Buy and raises the price target from $535 to $545.
01-27 01:56
美股大行评级 | 英特尔绩后获多家大行上调目标价；理想汽车、Mobileye、Meta、微软、甲骨文等遭下调目标价
今日重点评级关注：RBC Capital：维持Compass Pathways"跑赢大市"评级，目标价从16美元升至21美元；RBC Capital：维持GH Research"跑赢大市"评级，目标价从33美元升至40美元
01-26 14:32
美股大行评级 | 潜在涨幅258.31%！Tempest Therapeutics获HC Wainwright上调评级至"买入"，目标价11美元
今日重点评级关注：HC Wainwright & Co.：上调Tempest Therapeutics评级至"买入"，目标价11美元；Guggenheim：维持Sportradar Gr"买入"评级，目标价从34美元升至35美元
01-23 19:46
U.S. RESEARCH ROUNDUP-Cencora, Crocs, Teledyne Technologies
U.S. RESEARCH ROUNDUP-Cencora, Crocs, Teledyne Technologies Jan 22 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Cencora, Crocs and Teledyne Technologies, on Thursday. HIGHLIGHTS * Cencora COR.N : Jefferies raises to b
01-22 15:17
Why Is Vertex Pharmaceuticals (VRTX) Stock Trending Overnight?
Vertex Pharmaceuticals shares dipped slightly in after-hours trading following Wednesday's session.
01-22 13:07
Here's How Much $100 Invested In Vertex Pharmaceuticals 15 Years Ago Would Be Worth Today
Vertex Pharmaceuticals (NASDAQ:VRTX) has outperformed the market over the past ...
01-17 06:45
美股大行评级 | 瑞银上调美光科技目标价从300美元升至400美元；Freedom上调百度目标价从120美元升至160美元
今日重点评级关注：Needham：维持Vaxcyte"买入"评级，目标价从90美元升至110美元；Citizens: 维持LGI Homes"跑赢大市"评级，目标价从85美元升至95美元
01-08 18:33
美股大行评级 | 拼多多、小鹏获Freedom上调目标价；多家大行首予Wealthfront"超配"评级，目标价最高23美元
今日重点评级关注：HC Wainwright & Co.：维持MetaVia Inc."买入"评级，目标价从12美元升至40美元；Canaccord Genuity：维持GH Research"买入"评级，目标价从35美元升至39美元
01-07 17:25
Wolfe Research Upgrades Vertex Pharmaceuticals to Outperform, Announces $548 Price Target
Wolfe Research analyst Andy Chen upgrades Vertex Pharmaceuticals (NASDAQ:VRTX) from Peer Perform to Outperform and announces $548 price target.
01-06 21:17
